14-104938592-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138420.4(AHNAK2):āc.16859A>Cā(p.Gln5620Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q5620R) has been classified as Uncertain significance.
Frequency
Consequence
NM_138420.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AHNAK2 | NM_138420.4 | c.16859A>C | p.Gln5620Pro | missense_variant | 7/7 | ENST00000333244.6 | |
AHNAK2 | NM_001350929.2 | c.16559A>C | p.Gln5520Pro | missense_variant | 7/7 | ||
AHNAK2 | XM_024449463.2 | c.16559A>C | p.Gln5520Pro | missense_variant | 7/7 | ||
AHNAK2 | XM_047430904.1 | c.16559A>C | p.Gln5520Pro | missense_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AHNAK2 | ENST00000333244.6 | c.16859A>C | p.Gln5620Pro | missense_variant | 7/7 | 5 | NM_138420.4 | P1 | |
AHNAK2 | ENST00000557457.1 | c.1853A>C | p.Gln618Pro | missense_variant | 3/3 | 1 | |||
AHNAK2 | ENST00000555122.1 | n.16987A>C | non_coding_transcript_exon_variant | 6/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000283 AC: 7AN: 247656Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134574
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1460970Hom.: 0 Cov.: 73 AF XY: 0.0000234 AC XY: 17AN XY: 726728
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.16859A>C (p.Q5620P) alteration is located in exon 7 (coding exon 7) of the AHNAK2 gene. This alteration results from a A to C substitution at nucleotide position 16859, causing the glutamine (Q) at amino acid position 5620 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at